Literature DB >> 10458961

Smallpox: clinical and epidemiologic features.

D A Henderson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10458961      PMCID： PMC2627742          DOI： 10.3201/eid0504.990415

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


× No keyword cloud information.
  1 in total

1.  Bioterrorism as a public health threat.

Authors:  D A Henderson
Journal:  Emerg Infect Dis       Date:  1998 Jul-Sep       Impact factor: 6.883
  1 in total
  25 in total

Review 1.  Bioterrorism: implications for the clinical microbiologist.

Authors:  W F Klietmann; K L Ruoff
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Does smallpox still pose a threat?

Authors:  E Weir
Journal:  CMAJ       Date:  2001-11-13       Impact factor: 8.262

3.  Role for CCR5 in dissemination of vaccinia virus in vivo.

Authors:  Ramtin Rahbar; Thomas T Murooka; Eleanor N Fish
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

4.  Dynamics in a simple evolutionary-epidemiological model for the evolution of an initial asymptomatic infection stage.

Authors:  Chadi M Saad-Roy; Ned S Wingreen; Simon A Levin; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-08       Impact factor: 11.205

Review 5.  Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.

Authors:  Stephen R Walsh; Raphael Dolin
Journal:  Expert Rev Vaccines       Date:  2011-08       Impact factor: 5.217

6.  Simultaneous Detection of CDC Category "A" DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays.

Authors:  Jie He; Andrea J Kraft; Jiang Fan; Meredith Van Dyke; Lihua Wang; Michael E Bose; Marilyn Khanna; Jacob A Metallo; Kelly J Henrickson
Journal:  Viruses       Date:  2009       Impact factor: 5.048

7.  Modeling potential responses to smallpox as a bioterrorist weapon.

Authors:  M I Meltzer; I Damon; J W LeDuc; J D Millar
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

8.  New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens.

Authors:  Alexandre Borovkov; D Mitch Magee; Andrey Loskutov; Jose A Cano; Cheryl Selinsky; Jason Zsemlye; C Rick Lyons; Kathryn Sykes
Journal:  Virology       Date:  2009-10-02       Impact factor: 3.616

9.  Rapid and high-throughput pan-Orthopoxvirus detection and identification using PCR and mass spectrometry.

Authors:  Mark W Eshoo; Chris A Whitehouse; Aysegul Nalca; Scott Zoll; Joseph A Ecker; Thomas A Hall; Thuy-Trang D Pennella; David D Duncan; Anjali Desai; Emily K Moradi; Karl Rudnick; Brian Libby; Raymond Ranken; Rangarajan Sampath; Steven A Hofstadler; David J Ecker; Lawrence B Blyn
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

10.  ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification.

Authors:  Robert Jordan; Arthur Goff; Annie Frimm; Michael L Corrado; Lisa E Hensley; Chelsea M Byrd; Eric Mucker; Josh Shamblin; Tove' C Bolken; Carly Wlazlowski; Wendy Johnson; Jennifer Chapman; Nancy Twenhafel; Shanthakumar Tyavanagimatt; Adams Amantana; Jarasvech Chinsangaram; Dennis E Hruby; John Huggins
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.938
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.